Credit Suisse Group set a €106.00 ($123.26) price objective on Merck KGaA (FRA:MRK) in a report issued on Wednesday morning. The firm currently has a neutral rating on the healthcare company’s stock.

Several other research firms have also weighed in on MRK. Morgan Stanley set a €103.00 ($119.77) target price on Merck KGaA and gave the company a neutral rating in a report on Monday, May 15th. DZ Bank AG reaffirmed a neutral rating on shares of Merck KGaA in a research note on Thursday, May 11th. BNP Paribas set a €114.00 ($132.56) price objective on Merck KGaA and gave the company a buy rating in a research note on Wednesday, May 10th. Commerzbank Ag set a €109.00 ($126.74) price objective on Merck KGaA and gave the company a neutral rating in a research note on Wednesday, May 10th. Finally, J P Morgan Chase & Co reaffirmed a neutral rating on shares of Merck KGaA in a research note on Monday, May 8th. Two equities research analysts have rated the stock with a sell rating, sixteen have given a hold rating and five have issued a buy rating to the company. Merck KGaA has an average rating of Hold and a consensus target price of €109.55 ($127.38).

Merck KGaA (FRA MRK) opened at 93.32 on Wednesday. Merck KGaA has a 12-month low of €89.00 and a 12-month high of €115.00. The stock has a market cap of €40.52 billion and a price-to-earnings ratio of 26.02. The stock’s 50 day moving average price is €103.96 and its 200 day moving average price is €104.56.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/merck-kgaa-mrk-given-a-106-00-price-target-by-credit-suisse-group-analysts/1462118.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.